PATENT CLAIM ANALYSIS

Application Number: 15988819
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["435", "370000"]

Abstract:
The present invention discloses cryopreserved recombinant cells for screening drug candidates that transiently overexpress one or more drug transporter proteins and/or drug metabolizing enzymes. Advantageously, such cells provide a cost-efficient consumable product that streamlines the process of screening whether drug candidates are substrates or inhibitors of drug transporter proteins and/or drug metabolizing enzymes.

Claim (Index 28):
A cryopreserved transiently transfected recombinant cell prepared according to the process of  claim 26 .

Metadata:
- Claim Count in Document: 23.0
- Percentile: 93.0
- Lexical Diversity: 1.4359
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15688983', '14972012', '15163218', '15988802', '15688942']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8596645020957523
- 35 USC 102 Novelty (BERT): 0.6829997113140348
- Combined Prediction Score: 0.8419980230175806
- Mean Citation Score: 835.9224179999999
- Max Citation Score: 837.5606700000003
- Similarity Product: 673.4826652644002

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test